DOPTELET® (avatrombopag)

As a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases where there is a high unmet medical need, we aggressively pursue much-needed medicine. This work began with the development of DOPTELET®, which is approved by the U.S. Food & Drug Administration (FDA).

DOPTELET® (avatrombopag) tablets